Allopregnanolone as a Regenerative Therapeutic for Alzheimer's Disease (AD): A phase 2 proof-of-concept clinical trial using hippocampal volume as a surrogate endpoint

被引：0
|
作者：
Rivera, Gerson Hernandez [1 ]
Lopez, Claudia [1 ]
Raikes, Adam [1 ]
Rodgers, Kathleen [1 ]
Matthews, Dawn [2 ]
Schneider, Lon [3 ]
Brinton, Roberta [1 ]
机构：
[1] Univ Arizona, Ctr Innovat Brain Sci, Tucson, AZ USA
[2] ADM Diagnost, Northbrook, IL USA
[3] USC Sch Med, Los Angeles, CA USA
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000202953
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P8-6.008
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Improvements in clinical signs of Parkinson’s disease using photobiomodulation: a prospective proof-of-concept study
    Ann Liebert
    Brian Bicknell
    E-Liisa Laakso
    Gillian Heller
    Parastoo Jalilitabaei
    Sharon Tilley
    John Mitrofanis
    Hosen Kiat
    BMC Neurology, 21
  • [22] Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer's disease
    Cummings, Jeffrey L.
    Zhong, Kate
    Kinney, Jefferson W.
    Heaney, Chelcie
    Moll-Tudla, Joanne
    Joshi, Abhinay
    Pontecorvo, Michael
    Devous, Michael
    Tang, Anne
    Bena, James
    ALZHEIMERS RESEARCH & THERAPY, 2016, 8
  • [23] Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's disease
    Wang, Guoqiao
    Li, Yan
    Xiong, Chengjie
    Benzinger, Tammie L. S.
    Gordon, Brian A.
    Hassenstab, Jason
    Aschenbrenner, Andrew J.
    McDade, Eric
    Clifford, David B.
    Libre-Guerra, Jorge J.
    Shi, Xinyu
    Mummery, Catherine J.
    van Dyck, Christopher H.
    Lah, James J.
    Honig, Lawrence S.
    Day, Gregg
    Ringman, John M.
    Brooks, William S.
    Fox, Nick C.
    Suzuki, Kazushi
    Levin, Johannes
    Jucker, Mathias
    Delmar, Paul
    Bittner, Tobias
    Bateman, Randall J.
    ALZHEIMERS & DEMENTIA, 2024, 20 (04) : 2698 - 2706
  • [24] A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody (vol 13, 80, 2021)
    Swanson, Chad J.
    Zhang, Yong
    Dhadda, Shobha
    Wang, Jinping
    Kaplow, June
    Lai, Robert Y. K.
    Lannfelt, Lars
    Bradley, Heather
    Rabe, Martin
    Koyama, Akihiko
    Reyderman, Larisa
    Berry, Donald A.
    Berry, Scott
    Gordon, Robert
    Kramer, Lynn D.
    Cummings, Jeffrey L.
    ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)
  • [25] Proof-of-concept clinical trial on the use of oral ridaforolimus, an investigational mTOR inhibitor, for enhanced autophagy in Parkinson's disease
    Machado, D. G.
    Jabbari, B.
    MOVEMENT DISORDERS, 2010, 25 (07) : S300 - S300
  • [26] Cxcr2 Antagonist Mk-7123-A Phase 2 Proof-Of-Concept Trial For Chronic Obstructive Pulmonary Disease
    Rennard, S. I.
    Dale, D. C.
    Donohue, J. F.
    Kanniess, F.
    Magnussen, H.
    Sutherland, E. R.
    Watz, H.
    Lu, S.
    Stryszak, P.
    Rosenberg, E.
    Staudinger, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [27] CXCR2 Antagonist MK-7123 A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease
    Rennard, Stephen I.
    Dale, David C.
    Donohue, James F.
    Kanniess, Frank
    Magnussen, Helgo
    Sutherland, E. Rand
    Watz, Henrik
    Lu, Susan
    Stryszak, Paul
    Rosenberg, Elizabeth
    Staudinger, Heribert
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191 (09) : 1001 - 1011
  • [28] Clinical proof-of-concept trial to assess the therapeutic effect of sirolimus in patients with autosomal dominant polycystic kidney disease: SUISSE ADPKD study
    Serra A.L.
    Kistler A.D.
    Poster D.
    Struker M.
    Wüthrich R.P.
    Weishaupt D.
    Tschirch F.
    BMC Nephrology, 8 (1)
  • [29] Effects of aerobic exercise on cognition and hippocampal volume in Alzheimer's disease: study protocol of a randomized controlled trial (The FIT-AD trial)
    Yu, Fang
    Bronas, Ulf G.
    Konety, Suma
    Nelson, Nathaniel W.
    Dysken, Maurice
    Jack, Clifford, Jr.
    Wyman, Jean F.
    Vock, David
    Smith, Glenn
    TRIALS, 2014, 15
  • [30] Effects of aerobic exercise on cognition and hippocampal volume in Alzheimer’s disease: study protocol of a randomized controlled trial (The FIT-AD trial)
    Fang Yu
    Ulf G Bronas
    Suma Konety
    Nathaniel W Nelson
    Maurice Dysken
    Clifford Jack
    Jean F Wyman
    David Vock
    Glenn Smith
    Trials, 15
12345